Gyanza Bio Raises $7 Million in Seed Funding to Expand Operations and Develop Therapeutic Delivery Platform

Granza Bio raises over $7M in Seed Funding

Granza Bio (Linkedin), a UK-based therapeutic delivery platform developer, has secured over $7 million in seed funding. With a focus on targeted therapeutic cargo, Granza Bio aims to revolutionize the biotech and pharmaceutical industries with their innovative delivery platform.

Funding Amount: Over $7 million

Industry: Oil and Gas

Employee Count: 501-1000

CEO: Ashwin Menon Nandakumar (CEO Linkedin)

What Granza Bio needs to buy: Granza Bio is seeking partnerships with biotech and pharmaceutical companies, research institutions, and healthcare providers. Companies specializing in research and development collaboration, manufacturing and supply chain solutions, and marketing and sales support are ideal partners for Granza Bio to further develop and promote their innovative therapeutic delivery platform.